Studying organ crosstalk leads to a deeper understanding of sepsis

Findings reported in The American Journal of Pathology illustrate the metabolic components underlying the pathophysiological process of sepsis that have been a mystery for decades and have the potential to reduce mortality and morbidity


Philadelphia, August 20, 2019

Sepsis, a complex systemic response to infection leading to organ failure, is generally studied at the level of individual organs; this research has hinted at altered metabolic changes. A new study in The American Journal of Pathology, published by Elsevier, takes a two-pronged approach and investigates for the first time the metabolic changes across affected organs in a large animal model of sepsis and identifies both potential common and organ-specific metabolic alterations contributing to the disease process.

Lead investigator Monte S. Willis, MD, PhD, MBA, Co-Director of the Indiana Center for Musculoskeletal Health; Vice-Chair of Research, Department of Pathology and Laboratory Medicine; and Professor, Krannert Institute of Cardiology, at the Indiana University School of Medicine, Indianapolis, IN, USA, describes sepsis as “an inter-organ network issue.”

“Part of the issue with improving sepsis outcomes is due to our limited understanding of the pathological process,” explains Dr. Willis. “While the metabolic crosstalk of organs is taught conceptually, we tend to think of diseases in an organ-specific manner. We need to go beyond treatments that just target symptoms. Our studies illustrate that a broader system view of disease is needed and that metabolic intermediates may be responsible regulators of sepsis and other diseases.”

In this study, pigs were infected with Pseudomonas aeruginosa (P. aeruginosa), a common bacterium found in soil, water and plants. Individuals can become ill from eating P. aeruginosa–contaminated food or touching infected moist areas or improperly cleaned medical equipment. Eighteen hours after infection, investigators analyzed tissue samples from the pigs’ intestine, skeletal muscle, liver and lungs to determine how specific metabolic pathways were affected across organs.

Researchers identified both common metabolic alterations and organ-specific changes in a wider range of metabolic processes than previously reported. Organ-specific deficits in metabolism were also identified, with potential therapeutic implications.

“The observed organ-specific metabolic alterations provide clues to previously unexplored mechanisms of disease, while common metabolic alterations illustrate a broader array of changes than previously reported in individual organ studies. These studies provide insight into the potential for cross-communication among tissues in system disease and how specific organ damage may require therapeutic interventions targeting metabolism,” notes first author Amro Ilaiwy, MD, of the Sarah W. Stedman Nutrition and Metabolism Center, Duke Molecular Physiology Institute, Duke University Medical Center, Durham, NC, USA.

Dr. Willis and his co-investigators emphasize the need to understand disease processes as a network of communicating organs instead of focusing on an isolated organ. Given a basic acceptance of metabolic crosstalk in diseases such as diabetes, there is a basis for expanding these concepts into other complex diseases in other disciplines, such as skeletal muscle and the heart.

An estimated 1.7 million US adults develop sepsis annually, resulting in almost 270,000 deaths. Sepsis produces complex hemodynamic and cellular changes including tissue damage and organ failure, leading to inadequate oxygen delivery to cells. Treatments generally target symptoms such as low blood pressure or the bacteria responsible for infection, but do not address the underlying pathophysiology that occurs in affected organs. Understanding the underlying pathophysiology occurring in affected organs has been a challenge. Some scientists believe that progress may have been somewhat stymied by approaches that either focus too narrowly on individual organs or aim too broadly at detecting widespread metabolic changes.

---

Notes for editors
The article is “Identification of Metabolic Changes in Ileum, Jejunum, Skeletal Muscle, Liver, and Lung in a continuous I.V. Pseudomonas aeruginosa Model of Sepsis Using Nontargeted Metabolomics Analysis,” by Amro Ilaiwy, MD, Gabriella A.M. ten Have, PhD, James R. Bain, PhD, Michael J. Muehlbauer, PhD, Sara K. O’Neal, MS, Jessica M. Berthiaume, PhD, Traci L. Parry, PhD, Nicolaas E. Deutz, MD, PhD, and Monte S. Willis, MD, PhD (https://doi.org/10.1016/j.ajpath.2019.05.021). It will appear in The American Journal of Pathology, volume 189, Issue 9 (September 2019) published by Elsevier.

This work was supported by the National Institutes of Health (R01GM084447, S10RR027047, and R01HL104129).

Full text of the study is available to credentialed journalists upon request; contact Eileen Leahy at +1 732 238 3628 or ajpmedia@elsevier.com. Journalists wishing to interview the authors should contact Monte S. Willis, MD, PhD, at willisms@iu.edu or Christina Griffiths, IU School of Medicine, Media Relations Team, at +1 317 671 3114, or griffchm@iu.edu.

About The American Journal of Pathology
The American Journal of Pathology
, official journal of the American Society for Investigative Pathology, published by Elsevier, seeks high-quality original research reports, reviews, and commentaries related to the molecular and cellular basis of disease. The editors will consider basic, translational, and clinical investigations that directly address mechanisms of pathogenesis or provide a foundation for future mechanistic inquiries. Examples of such foundational investigations include data mining, identification of biomarkers, molecular pathology, and discovery research. High priority is given to studies of human disease and relevant experimental models using molecular, cellular, and organismal approaches. ajp.amjpathol.org

About Elsevier
Elsevier is a global information analytics business that helps scientists and clinicians to find new answers, reshape human knowledge, and tackle the most urgent human crises. For 140 years, we have partnered with the research world to curate and verify scientific knowledge. Today, we’re committed to bringing that rigor to a new generation of platforms. Elsevier provides digital solutions and tools in the areas of strategic research management, R&D performance, clinical decision support, and professional education; including ScienceDirect, Scopus, SciVal, ClinicalKey and Sherpath. Elsevier publishes over 2,500 digitized journals, including The Lancet and Cell, 39,000 e-book titles and many iconic reference works, including Gray's Anatomy. Elsevier is part of RELX, a global provider of information-based analytics and decision tools for professional and business customers. www.elsevier.com

Media contacts
Eileen Leahy
Elsevier
+1 732 238 3628
ajpmedia@elsevier.com

Chhavi Chauhan, PhD, Director of Scientific Outreach
The American Journal of Pathology
+1 240 283 9724
cchauhan@asip.org